The World's Best Liquid Biopsy from Datar Genetics Limited, India.
Cancertrack is a multi-coordinate, multi-dimensional, blood based liquid biopsy for diagnosis, therapy management and recurrence monitoring for cancer.
Cancertrack™ Interrogates*
• 22000+ DNA mutations
• 22,000 genes of mRNA
• 630+ genes of miRNA
• 500+ Fusions / Rearrangements
• Circulating Tumor Cells / Emboli
*Bio-markers Relevant for the purpose of the test
Cancertrack provides a real-time, comprehensive molecular profiling of the cancer, which is neither feasible nor practical with conventional invasive biopsies.
Cancertrack has 99.9 % analytical sensitivity and specificity at detection limit of 2 copies of mutant DNA per ml of patient plasma. Cancertrack is available for Solid Organ Cancers (Including Lung, Breast, Prostate, Colon, Pancreas, Ovary and many more), Gliomas and Sarcomas. We require 10-15 ml of blood draw to perform the analysis. Report is made available in 2-3 weeks, depending upon the requested test.
Advantages of Cancertrack™
• Non invasive alternative to invasive biopsy for comprehensive tumor molecular profiling
• Covers all relevant predictive and prognostic biomarkers (100% NCCN coverage)
• Aids in therapy selection and monitoring therapy response
• Enables real time monitoring of cancer dynamics including detection of acquired resistance
• No hospitalization/ No anesthesia/ No cuts or stitches
Company Details
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Liquid Biopsy Questions
Liquid Biopsy's LinkedIn profile is https://www.linkedin.com/company/liquidbiopsy
Liquid Biopsy's industry is
Biotechnology Research
Liquid Biopsy's categories are Biotechnology Research
